|
Volumn 48, Issue 11, 2007, Pages 2096-2097
|
Biology and clinical features of myeloid neoplasms with inv(3)(q21q26) or t(3;3)(q21q26)
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACUTE GRANULOCYTIC LEUKEMIA;
ALLOGENEIC STEM CELL TRANSPLANTATION;
BONE MARROW TUMOR;
CANCER CHEMOTHERAPY;
CANCER REGRESSION;
CANCER SURVIVAL;
CHROMOSOME 3Q;
CHROMOSOME ABERRATION;
CHROMOSOME INVERSION;
CHROMOSOME TRANSLOCATION;
CLINICAL FEATURE;
GENE EXPRESSION;
GENE FUSION;
GENETIC TRANSCRIPTION;
HUMAN;
MYELODYSPLASTIC SYNDROME;
NOTE;
ONSET AGE;
OUTCOME ASSESSMENT;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROGNOSIS;
SAMPLE SIZE;
THROMBOCYTE COUNT;
TRANSCRIPTION REGULATION;
TREATMENT RESPONSE;
CHROMOSOMES, HUMAN, PAIR 3;
HUMANS;
INVERSION, CHROMOSOME;
LEUKEMIA, MYELOID, ACUTE;
MYELODYSPLASTIC SYNDROMES;
PROGNOSIS;
TRANSLOCATION, GENETIC;
|
EID: 36048936452
PISSN: 10428194
EISSN: 10292403
Source Type: Journal
DOI: 10.1080/10428190701713671 Document Type: Note |
Times cited : (5)
|
References (7)
|